Mithramycin (NSC 24559) therapy of testicular tumors.
D000230:Adenocarcinoma / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004407:Dysgerminoma / Q000188:drug therapy; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy; D010689:Phlebitis / Q000139:chemically induced; D008926:Plicamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013724:Teratoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D008926:Plicamycin